ArticleFrontiers in pharmacology2025

First-in-human study of CPL'116 - a dual JAK/ROCK inhibitor - in healthy subjects.

Piotr J Rudzki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.